ClinicalTrials.Veeva

Menu

Comparative Study of the VeraCept Low-Dose Intrauterine Copper Contraceptive vs. the TCu380 Copper IUD

S

Sebela Pharmaceuticals

Status and phase

Completed
Phase 1

Conditions

Prevention of Pregnancy

Treatments

Device: VeraCept Intrauterine Copper Contraceptive
Device: TCu380 IUD

Study type

Interventional

Funder types

Industry

Identifiers

NCT02167763
CM2010.01

Details and patient eligibility

About

The purpose of this study is to evaluate the safety and effectiveness of the VeraCept Low Dose Intrauterine Copper Contraceptive compared to the standard T shaped copper IUD, the TCu380.

Full description

This is a prospective, randomized, subject-blinded, two arm controlled study of the Safety, Feasibility and Effectiveness of the VeraCept low-dose intrauterine copper contraceptive as compared to a concurrently controlled, commercially available standard copper "T" IUD (TCu380).

Enrollment

300 estimated patients

Sex

Female

Ages

18 to 42 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adult females ages 18 to 42 (pre-menopausal)
  • Have had at least one child (parous) and currently seeking long acting reversible contraception
  • Normal uterine cavity as determined by ultrasound
  • Willing to sign informed consent
  • Able and willing to comply with study assessment schedule

Exclusion criteria

  • Post menopausal
  • Pregnant (at time of enrollment)
  • Known anatomical abnormalities of uterus, cervix and/or fallopian tubes
  • Diagnosed or in treatment for cancer
  • Untreated acute cervicitis
  • In treatment for active Pelvic Inflammatory Disease
  • Unexplained uterine bleeding or menometrorrhagia
  • Known allergy to copper (Wilson's Disease) or imaging contrast media
  • Unsuitable for study participation in the opinion of the Principal Investigator

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

300 participants in 2 patient groups

VeraCept Intrauterine Contraceptive
Experimental group
Description:
The VeraCept low-dose Intrauterine Copper Contraceptive
Treatment:
Device: VeraCept Intrauterine Copper Contraceptive
TCu380
Active Comparator group
Description:
A commercial standard T-shaped copper IUD (TCu380)
Treatment:
Device: TCu380 IUD

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems